Crane Company

Rank #293Capital Return

CR · NYSE · Industrials

Crane Company (CR) — Rank #293 by gross profitability (GP/assets 0.24) · ROE 16.8% · Piotroski F-Score 5 / 9.

As-of 2026-09-15 · CIK 0001944013 · all metrics point-in-time as of the filing date.

About

Crane Company, together with its subsidiaries, engages in the manufacture and sale of engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally.

The company operates in two segments, Aerospace & Advanced Technologies and Process Flow Technologies. The Aerospace & Electronics segment supplies critical components and systems, including original equipment and aftermarket parts for commercial aerospace, as well as the military aerospace, defense, and space markets. This segment also offers pressure sensors for aircraft engine control, aircraft braking systems for commercial aircraft and fighter jets, power conversion solutions for defense, and space applications and lubrication systems. The Process Flow Technologies segment provides process valves and related products, pumps and systems, and commercial valves; valve positioning and control systems, vacuum insulated pipe systems, and valve diagnostic and calibration systems; pumps and systems; and commercial valves. The company was formerly known as Crane Holdings, Co.

Crane Company was founded in 1855 and is based in Stamford, Connecticut.

Industry: Specialty Industrial Machinery
Sector: Industrials
State: DE
Filer Category: Large accelerated filer
Fiscal Year End: December 31
Website: craneco.com

Price History

CR+186.2% · +35.7% CAGRSPY+98.4% · +22.0% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

$11.30B

P/E (annual)

31.2

P/S (annual)

4.9

P/B

5.2

P/OCF (annual)

28.6

Shareholder Yield

-0.0%

Employees

8,300

Industry

Specialty Industrial Machinery

Exchange

NYSE

Signal Flags

4 green1 yellow

Operating leverage expandingOperating income growing faster than revenue

Deferred revenue growingRevenue and deferred revenue both growing — retention signal

RPO outpacing revenueRemaining performance obligations growing faster than recognized revenue — forward demand building

Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak

Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why

Quality Profile

Profitability

1/1 pass

GP / assets

0.24

Return on equity

16.8%

Gross margin trend

PASS

Safety

1/1 pass

Balance-sheet safety

PASS

Debt / equity

0.85

Current ratio

2.80×

Net cash

-$795.20M

Cash Flow

1/1 pass

Positive FCF

N/A

Cash-backed earnings

N/A

Accruals healthy

PASS

SBC / revenue

1.2%

Growth

2/2 pass

Revenue growth

8.2%

Piotroski F-Score

5 / 9

Share dilution

0.5%

Terry Smith quality gate

Passes 0/5 Terry Smith thresholds

2 of 5 thresholds not computable from filed data.

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

32.6xExpensive

16.9xmed 31.8x36.1x

P / S

Price / revenue per share

5.2xExpensive

3.6xmed 5.0x5.2x

P / B

Price / book value per share

5.8xExpensive

4.0xmed 5.7x6.8x

P / GP

Price / gross profit per share

12.3xExpensive

10.7xmed 12.3x13.9x

Earnings bubble check

Current margins may be above sustainable levels — a P/E based on peak earnings can overstate cheapness.

Net margin15.9% now vs 12.3%–15.9% 10yr range

1.5σ above average

Disclosure regression check

A previously-disclosed line item is no longer reported. Worth checking the filing for why.

SG&A expenseCost structure

last seen FY2024

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.24

Primary signal (Novy-Marx).

4th of 5 SIC 3490 peers

Return on equity

16.8%

Gross margin

42.2%

3rd of 5 SIC 3490 peers

Revenue growth (YoY)

8.2%

RPO growth (YoY)

15.7%

Remaining performance obligations growth — RPO > revenue = forward demand building.

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

	2022	2023	2024	2025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

9.1%

Revenue CAGR (5Y)

—

Earnings CAGR (3Y)

-3.0%

FCF CAGR (3Y)

—

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.85

3rd of 5 SIC 3490 peers (best = lowest)

Current ratio

2.80×

2nd of 5 SIC 3490 peers

Quick ratio

1.59×

Net cash

-$795.20M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

—

Operating cash flow minus capex.

Positive free cash flow

N/A

FCF / net income

—

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

N/A

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.2%

Stock-based comp intensity.

Dividend safety

Composite score

2.0 / 5

Fair

Payout ratio

14.4%5/5 Strong

FCF coverage

N/A0/5 Weak

Dividend growth streak

1 yr1/5 Weak

Balance-sheet health

D/E 0.85 · IC N/A2/5 Fair

Piotroski F-Score

F-Score

5 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

2021

2022-2025

20212025

Value

Capital Return

View full financial statements →